Q98530044
committee directives from 2011
Press Enter · cited answer in seconds
0 sources
Q98530044
Summary
Q98530044 is a committee directives[1].
Key Facts
- Q98530044 is in the country of Sweden[2].
- Q98530044's instance of is recorded as committee directives[3].
- Q98530044's part of the series is recorded as committee directives from 2011[4].
- Q98530044's language of work or name is recorded as Swedish[5].
- Q98530044's publication date is recorded as +2011-09-22T00:00:00Z[6].
- Q98530044's main subject is recorded as medication[7].
- Q98530044's work available at URL is recorded as http://data.riksdagen.se/dokument/GZB182.html[8].
- Q98530044's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GZB182[9].
- Q98530044's applies to jurisdiction is recorded as Sweden[10].
- Q98530044's legal citation of this text is recorded as dir. 2011:82[11].
- Q98530044's title is recorded as Tilläggsdirektiv till utredningen om vissa frågor om prissättning, tillgänglighet och marknadsförutsättningar inom läkemedels- och apoteksområdet (S 2011:07)[12].
- Q98530044's cites work is recorded as Q98139048[13].
- Q98530044's cites work is recorded as Q98129635[14].
- Q98530044's cites work is recorded as Q98129418[15].
- Q98530044's cites work is recorded as Q98530073[16].
- Q98530044's maintained by WikiProject is recorded as Project Riksdagen's documents[17].
- Q98530044's copyright status is recorded as public domain[18].
- Q98530044's Swedish Riksdag document ID is recorded as GZB182[19].